Bottom line
QAAHBX vs FHLC: the short answer
QAAHBX (T. Rowe Price Health Sciences Portfolio) and FHLC (Fidelity MSCI Health Care Index ETF) are both etfs.
FHLC is cheaper at 0.084% vs 1.11% — a difference of $103 a year per $10,000 invested.
Over five years, FHLC returned +7.2% a year vs +3.9% for QAAHBX (reporting dates differ).
Updated Nov 19, 2026
QAAHBX vs FHLC side by side
| QAAHBX | FHLC | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | T. Rowe Price | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.11% | 0.084% |
| Annual cost per $10k | $111 | $8.4 |
| 10-yr cost on $10k (prospectus) | $1,352 | $108 |
| Max front load | None | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +17.8% | +2.6% |
| 5-yr return (annualized) | +3.9% | +7.2% |
| 10-yr return (annualized) | +8.7% | +8.8% |
| Best quarter | +23.4% | +16.4% |
| Worst quarter | −15.8% | −13.1% |
| Net assets (fund) | $751.7M | $3.3B |
| Number of holdings | 277 | 337 |
| Portfolio turnover | 65% | 3% |
| Returns as of | Dec 31, 2025 | Nov 30, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of QAAHBX's top 25 holdings also appear in FHLC's top 25.
| Holding | QAAHBX | FHLC |
|---|---|---|
| Eli Lilly & Co | 14.06% | 13.35% |
| Johnson & Johnson | 6.64% | 8.93% |
| Unitedhealth Group Inc | 5.88% | 5.44% |
| Abbvie Inc | 5.12% | 6.42% |
| Merck & Co. Inc. | 4.00% | 4.66% |
| Gilead Sciences Inc | 2.79% | 2.34% |
| Thermo Fisher Scientific Inc | 2.53% | 3.09% |
| Vertex Pharmaceuticals Inc | 2.26% | 1.76% |
| Bristol-myers Squibb Co | 2.12% | 1.93% |
| Abbott Laboratories | 1.91% | 2.66% |
| Intuitive Surgical Inc | 1.89% | 1.82% |
| Amgen Inc | 1.80% | 3.00% |
| Stryker Corp | 1.78% | 1.62% |
| Elevance Health Inc | 1.54% | 1.19% |
| Danaher Corp | 1.44% | 1.80% |
Source: SEC Form N-PORT
QAAHBX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FHLC top 10
- Eli Lilly & Co — 13.35%
- Johnson & Johnson — 8.93%
- AbbVie Inc — 6.42%
- UnitedHealth Group Inc — 5.44%
- Merck & Co Inc — 4.66%
- Thermo Fisher Scientific Inc — 3.09%
- Amgen Inc — 3.00%
- Abbott Laboratories — 2.66%
- Gilead Sciences Inc — 2.34%
- Pfizer Inc — 2.06%
FAQ
What is the difference between QAAHBX and FHLC?
QAAHBX (T. Rowe Price Health Sciences Portfolio) and FHLC (Fidelity MSCI Health Care Index ETF) are both etfs. FHLC is cheaper at 0.084% vs 1.11% — a difference of $103 a year per $10,000 invested.
Which is cheaper, QAAHBX or FHLC?
FHLC has the lower expense ratio (0.084%).
Should I own both QAAHBX and FHLC?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.